Tourniquet Complications in Orthopaedic Surgery

The purpose of the study is to establish the number and nature of complications that we, the researchers, have with the use of a tourniquet in orthopaedic surgery in Norway.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tourniquet Complications Neoplasms Neoplasms by Histologic Type Neoplasms, Nerve Tissue Nerve Compression Nerve Sheath Neoplasms Nervous System Diseases Neurologic Manifestations Neuroma Palsy Paralysis Paresis Pathological Conditions, Signs and Symptoms Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

St Olavs Hospital

Trondheim, 7006, Norway

About this study

This is a multicenter, prospective study where contact persons in 10 different hospitals throughout Norway monitor problems and complications that occur in relation with tourniquet use in orthopaedic surgery. If a complication occurs, it is documented in detail by the contact person.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients in 10 orthopaedic hospitals in Norway undergoing surgery which requires a tourniquet, from 1 january to 31 of december 2005

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Registry information

Official study title

A Prospective, Epidemiological Study of the Incidence and Nature of Tourniquet Complications in Norway

Important dates

Study start: 2005
Primary completion: 2005
Study completion: 2005
First posted: Sep 21, 2005
Registry last updated: Mar 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed